Literature DB >> 30133646

Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood.

Marisa Liliana Fernández1, Yolanda Hernández1, Karenina Scollo2, Mónica Ines Esteva3, Adelina Rosa Riarte1, Nilda Graciela Prado1.   

Abstract

Chagas disease is a chronic parasitological disease, which could cause cardiac manifestations in approximately one-third of affected individuals. Benznidazole and nifurtimox are used to treat this parasitological infection caused by Trypanosoma cruzi. Conventionally, the criterion for cure is consistently negative serological tests after treatment. We report a case of a patient who was treated when she was 13 years old and achieved T. cruzi negative seroconversion but developed Chagas disease cardiomyopathy as an adult.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30133646     DOI: 10.1590/0037-8682-0364-2017

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  3 in total

1.  Age-related anomalies of electrocardiograms in patients from areas with differential Seroprevalence of Chagas disease in Southern Bolivia.

Authors:  Jhean-Carla Echalar; David Veliz; Omar N Urquizo; Hermann M Niemeyer; Carlos F Pinto
Journal:  Parasite Epidemiol Control       Date:  2021-02-03

2.  Declining antibody levels to Trypanosoma cruzi correlate with polymerase chain reaction positivity and electrocardiographic changes in a retrospective cohort of untreated Brazilian blood donors.

Authors:  Lewis F Buss; Léa Campos de Oliveira-da Silva; Carlos H V Moreira; Erika R Manuli; Flavia C Sales; Ingra Morales; Clara Di Germanio; Cesar de Almeida-Neto; Sonia Bakkour; Paul Constable; Marcelo M Pinto-Filho; Antonio L Ribeiro; Michael Busch; Ester C Sabino
Journal:  PLoS Negl Trop Dis       Date:  2020-10-27

3.  Serological response to nifurtimox in adult patients with chronic Chagas disease: An observational comparative study in Argentina.

Authors:  David Vizcaya; Ulrike Grossmann; Frank Kleinjung; Ruiping Zhang; Kiliana Suzart-Woischnik; Sandra Seu; Teresa Ramirez; Leylen Colmegna; Oscar Ledesma
Journal:  PLoS Negl Trop Dis       Date:  2021-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.